Results of a clinical study recently published in the scientific journal “The International journal of Lower Extremity Wound” show Nexodyn® AcidOxidizing Solution to promote the restart of wound healing process.
According to the outcomes of the study, Nexodyn® AOS thanks to its unique physico-chemical properties – highly pure stabilized hypochlorous acid (HClO >95% of free chlorine species), acidic pH (2.5-3) and high oxidation reduction potential – confirmed to be able to restart wound healing by creating the ideal microenvironment to sustain the physiological healing process.
Nexodyn® AOS demonstrated significant reduction (number of days) in healing time when applied on top of the standard of care: lesions treated with Nexodyn® AOS required half the time to recover (64.9+/- 12.1 days vs 147.41/- 23.1 days; p<0.01) vs lesions undergoing standard treatment.
On the other side, the reinfection rate was significantly lower in Nexodyn® AOS patients in comparison with the ones who were not administered the solution (3 patients vs 12 patients; p<0.05); patients in the Nexodyn® AOS group showed also lower need for further debridement procedures (-90%; p<0.05), with potential reduction of hospital costs.
Full publication “Iacopi E. et al. The Use of a Novel Super-Oxidized Solution on Top of Standard Treatment in the Home Care Management of Postsurgical Lesions of the Diabetic Foot Reduces Reinfections and Shortens Healing Time. Int J Low Extrem Wounds. 2018 Dec; 17(4):268-274.” can be purchased on the journal’s website.
For more info about Nexodyn® AOS , please visit: https://www.apr.ch/apr-pharma-products/medical-prescription/nexodyn-wound-healing/